Topics

Patients with metastatic colorectal cancer harbouring certain BRAF mutations may respond to anti-EGFR

07:02 EDT 13 Sep 2019 | ecancermedicalscience

Patients with metastatic colorectal cancer harbouring a subset of non-V600 mutations in the BRAF gene, known as class 3 BRAF mutations, were more likely to respond to anti-EGFR treatment. Findings in the study were published in the journal Clinical...

Original Article: Patients with metastatic colorectal cancer harbouring certain BRAF mutations may respond to anti-EGFR

NEXT ARTICLE

More From BioPortfolio on "Patients with metastatic colorectal cancer harbouring certain BRAF mutations may respond to anti-EGFR"

Quick Search

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...